PharmaDiall Ltd.: Clinical Trials

3 trials sponsored by PharmaDiall Ltd., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 unknown. 1 Phase 1, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Unknown 1
Phase 31Completed 1

Follow PharmaDiall Ltd.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Trial of Dimolegin (DD217) in Prevention of Thrombotic Complications in Patients With COVID-19
Dimolegin, Clexane - COVID-19, Venous Thromboembolism
Phase 3CompletedPharmaDiall Ltd.3992021-02-082022-01-11
A Study to Evaluate Dimolegin in Prevention of Thromboembolic Complications During Knee Replacement
Dimolegin 40 mg, Dimolegin 60 mg, Fragmin - Venous Thromboembolism
Phase 2UnknownPharmaDiall Ltd.2402019-05-312022-05-02
A Study of Pharmacokinetics, Safety and Tolerability of Dimolegin (DD217)
Dimolegin - Healthy Volunteers
Phase 1CompletedPharmaDiall Ltd.242017-01-252022-01-06

Conditions studied

Venous Thromboembolism (2)  ·  COVID-19 (1)  ·  Pulmonary Embolism (1)  ·  Thrombosis (1)  ·  Venous Thrombosis (1)

Interventions

(+-)-(1'R*,2'S*,6'R*)-(2-hydroxy-4,6-dimethoxyphenyl)(3'-methyl-2'-(3''-methylbut-2''-enyl)-6-phenylcyclohex-3'-enyl)methanone (3)  ·  Dalteparin (1)  ·  Enoxaparin (1)  ·  enoxaparin sodium (1)

Countries

Russia (3)

Top investigators

Dmitry A Napalkov, Professor (2)